Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.

Close

Make a donation

The Dr Andrew R Belch Myeloma Education and Enriched Training (MEET) Grant

Myeloma Canada is proud to announce the establishment of a new grant exclusively for young Canadian myeloma investigators: The Dr Andrew R Belch Myeloma Education and Enriched Training (MEET) Grant.

The grant has been created to help foster the development as well as support the participation of young Canadian myeloma investigators at either the 2019 International Myeloma Workshop (IMW, Sept 12-15, 2019, Boston, MA) or the 2019 American Society of Hematology Conference (ASH, Dec 7-10, 2019 Orlando, FL).

A total of 6 MEET grants of CDN $4,000 each will be awarded. The grants are to be used exclusively to cover conference registration fees, travel and lodging for either IMW 2019 OR ASH 2019.

Dr Andrew Belch

The MEET grant has been created in recognition of the outstanding life-time achievements of Dr Andrew Belch in the field of multiple myeloma as well as his lifelong mentoring of young researchers.

Dr Belch has been an active supporter of Myeloma Canada and the Myeloma Canada Research Network (MCRN) since their inception, including having served as Chair of the Myeloma Canada Scientific Advisory Board.

To be eligible, applicants must:
• submit an abstract that is clinically directed, or clinically relevant for Canadian myeloma patients and must be selected for oral or poster presentation at IMW 2019 or ASH 2019;
• be 35 years of age or younger at the time of application;
• hold a PhD, MD, or equivalent medical degree;
• be currently enrolled in a Canadian residency program in the field of myeloma, with the intention of specializing in myeloma in Canada;
• be the primary author on the submitted abstract;
• be able to attend the conference, in person, to present their abstract;
• submit a completed application form to Myeloma Canada at andrewbelchgrant@myeloma.ca.

FULL DETAILS
 

APPLICATION DEADLINES:

International Myeloma Workshop (IMW) 2019
Sept 12-15, 2019, Boston, MA

  • June 19, 2019

Deadline for abstract submissions to IMW

  • June 30, 2019
Notifications from IMW to applicants regarding abstract acceptance
  • August 15, 2019

Submission deadline for MEET Grant application, with a copy of abstract acceptance from IMW, to Myeloma Canada

  • August 30, 2019

Myeloma Canada’s MEET Grant announced to winners

American Society of Hematology Conference (ASH) 2019
Dec 7 – 10, 2019, Orlando, FL

  • August 1, 2019

Deadline to submit abstract to ASH

  • 1st week October, 2019 

Notifications from ASH to applicants regarding abstract acceptance. Please check https://www.hematology.org/Annual-Meeting/Abstracts/2853.aspx for dates.

  • October 31, 2019

Submission deadline for MEET Grant application, with a copy of abstract acceptance from ASH, to Myeloma Canada.

  • November 7, 2019

Myeloma Canada’s MEET grant announced to winners

Note: If you choose to submit your MEET Grant application PRIOR to receiving your abstract acceptance from IMW or ASH, you must forward a copy of your abstract acceptance to Myeloma Canada by the MEET Grant submission deadline date in order to be considered eligible for the grant.

APPLICATION FORM

Please note: only email applications will be accepted.


For more information, please email us at andrewbelchgrant@myeloma.ca.
For questions, please contact Martine Elias at melias@myeloma.ca.